Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 2
2015 2
2016 1
2017 2
2018 4
2019 5
2020 7
2021 5
2022 7
2023 8
2024 5
2025 9
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Estrogen receptors in endocrine disorders.
Filardi T, Townsend KL, Lappano R, Caprio M. Filardi T, et al. Front Endocrinol (Lausanne). 2023 Nov 1;14:1325371. doi: 10.3389/fendo.2023.1325371. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027157 Free PMC article. No abstract available.
Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial.
Barchetta I, Filardi T, Dule S, Cimini FA, Sentinelli F, Romagnoli E, Passarella G, Bleve E, Oldani A, Venditti V, Anastasi E, Gandini O, Napoli N, Nicolucci A, Lenzi A, Baroni MG, Morano S, Cavallo MG; SlowDOWN Study Network. Barchetta I, et al. Among authors: filardi t. BMC Med. 2025 Oct 14;23(1):562. doi: 10.1186/s12916-025-04363-w. BMC Med. 2025. PMID: 41088165 Free PMC article. Clinical Trial.
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data.
Fadini GP, Longato E, Poletto S, Giaccari A, Ghiani M, Strazzabosco M, Trombetta M, Penno G, Avogaro A, Solini A, Consoli A; GLIMPLES study investigators and DARWIN‐Renal study investigators. Fadini GP, et al. Diabetes Obes Metab. 2025 Dec;27(12):7431-7440. doi: 10.1111/dom.70151. Epub 2025 Sep 24. Diabetes Obes Metab. 2025. PMID: 40990044 Free PMC article.
Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases.
Grieco M, Giorgi A, Gentile MC, d'Erme M, Morano S, Maras B, Filardi T. Grieco M, et al. Among authors: filardi t. Front Neurosci. 2019 Oct 18;13:1112. doi: 10.3389/fnins.2019.01112. eCollection 2019. Front Neurosci. 2019. PMID: 31680842 Free PMC article. Review.
MicroRNA Modulation by Dietary Supplements in Obesity.
Filardi T, Sabato C, Lubrano C, Santangelo C, Morano S, Lenzi A, Migliaccio S, Ferretti E, Catanzaro G. Filardi T, et al. Biomedicines. 2020 Nov 27;8(12):545. doi: 10.3390/biomedicines8120545. Biomedicines. 2020. PMID: 33261062 Free PMC article. Review.
Circulating Proneurotensin Levels Predict Impaired Bone Mineralisation in Postmenopausal Women With Type 2 Diabetes Mellitus.
Barchetta I, Dule S, Cimini FA, Sentinelli F, Oldani A, Passarella G, Filardi T, Venditti V, Bleve E, Romagnoli E, Morano S, Lenzi A, Melander O, Baroni MG, Cavallo MG. Barchetta I, et al. Among authors: filardi t. Diabetes Metab Res Rev. 2025 Jan;41(1):e70018. doi: 10.1002/dmrr.70018. Diabetes Metab Res Rev. 2025. PMID: 39655684 Free PMC article.
55 results